Effect of vitamin B-12 and n-3 polyunsaturated fatty acids on plasma homocysteine, ferritin, C-reactive protein, and other cardiovascular risk factors: A randomized controlled trial

Asia Pacific Journal of Clinical Nutrition

Volumn 24, Issue 3, 2015, Pages 403-411

  Huang, Tao ^a,b   Li, Kelei ^a,b   Asimi, Sailimuhan ^a,b   Chen, Qi ^a,b   Li, Duo ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b APCNS Centre of Nutrition and Food Safety   (China)

Author keywords

C reactive protein; Ferritin; Fish oil; Homocysteine; Vitamin B 12

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FERRITIN; FISH OIL; HOMOCYSTEINE; OMEGA 3 FATTY ACID; VITAMIN B COMPLEX;

ADULT; BLOOD; CARDIOVASCULAR DISEASE; CHINA; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECTS; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; YOUNG ADULT;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHINA; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FERRITINS; FISH OILS; HOMOCYSTEINE; HUMANS; MALE; RISK FACTORS; VITAMIN B 12; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 84948759548     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.2015.24.3.19     Document Type: Article

References (33)

1. Huang T, Yuan G, Zhang Z, Zou Z, Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac J Clin Nutr. 2008;17:8-16.
2. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr. 2005;82:806-12.
3. Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL. Folic acid-an innocuous means to reduce plasma homocysteine. Scand J Lab Invest. 1988;48:215-21. doi: 10.3109/00365518809167487.
4. Brattstrom L, Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A et al. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ. 1998;316:894-8. doi: 10.1136/bmj.316.7135.894.
5. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr. 2012;31:448-54. doi: 10.1016/j.clnu.2011.01.003.
6. Benito P, Caballero J, Moreno J, Gutierrez-Alcantara C, Munoz C, Rojo G et al. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr. 2006;25:581-7. doi: 10.1016/j.clnu.2005.12.006.
7. Li D, Yu XM, Xie HB, Zhang YH, Wang Q, Zhou XQ et al. Platelet phospholipiid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patents. PLEFA. 2007;76:293-7. doi: 10.101 6/j.plefa.2007.02.003.
8. Li D, Mann NJ, Sinclair AJ. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids. 2006;41:85-9. doi: 10.1007/s11745-006-50 74-x.
9. Zeman M, Zak A, Vecka M, Tvrzicka E, Pisarikova A, Stankova B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nutr Biochem. 2006;17:379-84. doi: 10.1016/j.jnutbio.2005.08.007.
10. Grundt H, Nilsen DWT, Mansoor MA, Hetland O, Nordoy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb. 2003;33:88-95. doi: 10.1159/000073852.
11. Olszewski AJ, Mccully KS. Fish oil decreases serum homocysteine in hyperlipemic men. Coronary Artery Dis. 1993;4:53-60. doi: 10.1097/00019501-199301000-00007.
12. Huang T, Zheng J, Chen Y, Yang B, Wahlqvist ML, Li D. High consumption of omega-3 polyunsaturated fatty acids decrease plasma homocysteine: a meta-analysis of randomized, placebo-controlled trials. Nutrition. 2011;27: 863-7. doi: 10.1016/j.nut.2010.12.011.
13. Reinders I, Virtanen JK, Brouwer IA, Tuomainen TP. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men. Eur J Clin Nutr. 2012;66:736-41. doi: 10.1038/ejcn.2011.195.
14. Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, Djuric I et al. Effects of n-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren fail. 2007;29:321-9. doi: 10.1080/08860220601184092.
15. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab. 2008;93:4690-6. doi: 10.1210/jc.2008-1159.
16. Mezzano D, Kosiel K, Martinez C, Cuevas A, Panes O, Aranda E et al. Cardiovascular risk factors in vegetarians. Normalization of hyperhomocysteinemia with vitamin B(12) and reduction of platelet aggregation with n-3 fatty acids. Thromb Res. 2000;100:153-60. doi: 10.1016/S0049-3848(00) 00313-3.
17. Zeman M, Zak A, Vecka M, Tvrzicka E, Pisarikova A, Stankova B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nutr Biochem. 2006;17:379-84. doi: 10.1016/j.jnutbio.2005.08.007.
18. Carrero JJ, Lopez-Huertas E, Salmeron LM, Ramos VE, Baro L, Ros E. Simvastatin and supplementation with n-3 polyunsaturated fatty acids and vitamins improves claudication distance in a randomized PILOT study in patients with peripheral vascular disease. Nutr Res. 2006; 26:37-43. doi: 10.1016/j.nutres.2006.09.024.
19. Grundt H, Nilsen DW, Mansoor MA, Hetland O, Nordoy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb. 2003;33:88-95. doi: 10.1159/000073852.
20. Carrero JJ, Lopez-Huertas E, Salmeron LM, Baro L, Ros E. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr. 2005;135:1393-9.
21. Carrero JJ, Fonolla J, Marti JL, Jimenez J, Boza JJ, Lopez-Huertas E. Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr. 2007;137:384-90.
22. Pooya S, Jalali MD, Jazayery AD, Saedisomeolia A, Eshraghian MR, Toorang F. The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2010;20:326-31. doi: 10.1016/j.numecd.2009.04.002.
23. Grundt H, Nilsen DW, Hetland O, Mansoor MA, Aarsland T, Woie L. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thromb Haemost. 1999;81:561-5.
24. Piolot A, Blache D, Boulet L, Fortin LJ, Dubreuil D, Marcoux C, Davignon J, Lussier-Cacan S. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med. 2003;141:41-9. doi: 10.1067/mlc. 2003.3.
25. Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B et al. Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur J Clin Invest. 1999;29:100-8. doi: 10.1046/j.1365-2362.1999.004 19.x.
26. Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients. Nephrology (Carlton). 2008;13:284-8. doi: 10.1111/j.1440-1797.2008.00934.x.
27. Holdt B, Korten G, Knippel M, Lehmann JK, Claus R, Holtz M et al. Increased serum level of total homocysteine in CAPD patients despite fish oil therapy. Perit Dial Int. 1996; 16(Suppl 1):S246-S9.
28. Xiu LL, Lee MS, Wahlqvist ML, Chen RC, Huang YC, Chen KJ et al. Low and high homocysteine are associated with mortality independent of B group vitamins but interactive with cognitive status in a free-living elderly cohort. Nutr Res. 2012;32:928-39. doi: 10.1016/j.nutres. 2012.09.005.
29. Huang T, Tucker K, Lee Y, Crott J, Parnell L, Shen J et al. MAT1A variants modulate the effect of dietary fatty acids on plasma homocysteine concentrations. Nutr Metab Cardiovasc Dis. 2012;22:362-8. doi: 10.1016/j.numecd.2010.07.015.
30. Huang T, Tucker KL, Lee YC, Crott JW, Parnell LD, Shen J et al. Methylenetetrahydrofolate reductase variants associ-ated with hypertension and cardiovascular disease interact with dietary polyunsaturated fatty acids to modulate plasma homocysteine in puerto rican adults. J Nutr. 2011;141:654-9. doi: 10.3945/jn.110.134353.
31. Huang T, Wahlqvist ML, Li D. Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism. Nutrition. 2010;26:112-9. doi: 10.1016/j.nut. 2009.05.015.
32. Li K, Huang T, Zheng J, Wu K, Li D. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor alpha: a meta-analysis. PloS One. 2014;9:e88103. doi: 10.1371/journal. pone.0088103.
33. Robinson LE, Buchholz AC, Mazurak VC: Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Appl Physiol Nutr Metab. 2007;32: 1008-24. doi: 10.1139/H07-087.